BGI has published a study tracking the clinical performance of its whole genome sequencing-based non-invasive prenatal test (the NIFTY test) in nearly 147,000 pregnancies, the largest such study to date. The results showed high sensitivity and specificity and no significant difference between high-risk and low-risk pregnant women.
from The Medical News http://ift.tt/1D4mRhL
from The Medical News http://ift.tt/1D4mRhL
No comments:
Post a Comment